A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Scott M. Dehm et al.|Cancer Immunology Research|2024Cited by 9
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Figure S10 from A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Nicholas A. Zorko et al.|Unknown|2025Cited by 0
Abstract 1241: Enhancing NK cell therapy for head and neck cancer within the solid tumor microenvironment using a B7H3-targeting tri-specific killer engager (TriKE)Melissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Cancer Research|2024Cited by 0
Figure S1 from A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Nicholas A. Zorko et al.|Unknown|2025Cited by 0